Therini Bio Pty Ltd
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy. (NCT06701721) | Therini Bio Pty Ltd | 2024-12-20 |
Track Therini Bio Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.